Moraga, CA, United States of America

Yuqiao Shen

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2013-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Yuqiao Shen: A Pioneer in PARP Inhibitor Research**

Introduction

Yuqiao Shen, an accomplished inventor based in Moraga, CA, has made significant contributions to the field of pharmaceutical science. With a total of three patents to his name, his work focuses primarily on the development of innovative inhibitors targeting poly(ADP-ribose) polymerase (PARP), which have implications in the treatment of diseases associated with PTEN deficiencies.

Latest Patents

Yuqiao’s latest patents involve the design of Dihydropyridophthalazinone inhibitors of PARP for therapeutic use. These compounds are designed to address conditions ameliorated by PARP activity inhibition, specifically targeting diseases associated with a PTEN deficiency. The patents detail the structure of these compounds, with specific substituents outlined in their respective formulas. The developments promise to advance treatment options through novel pharmaceutical compositions based on these inhibitors.

Career Highlights

Throughout her career, Yuqiao has been associated with notable organizations, including Biomarin Pharmaceutical Inc. and Medivation Technologies, Inc. Her tenure at these companies has provided her with a robust platform for innovation, enabling her to contribute to cutting-edge research in drug development and therapeutic applications.

Collaborations

Yuqiao has collaborated with esteemed colleagues such as Daniel T. Chu and Bing Wang. These partnerships reflect her commitment to fostering environments conducive to innovation and development in pharmaceutical research.

Conclusion

Yuqiao Shen exemplifies the spirit of innovation in the pharmaceutical industry. Her patents related to PARP inhibitors not only showcase her expertise but also highlight the potential for new therapeutic avenues in treating diseases linked to PTEN deficiencies. As the field evolves, her contributions will undoubtedly inspire further advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…